International Yearbook of Nephrology 1990 1990
DOI: 10.1007/978-1-4613-1491-2_4
|View full text |Cite
|
Sign up to set email alerts
|

Management of the Hyperlipidemia of the Nephrotic Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

1992
1992
2001
2001

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 51 publications
0
3
0
1
Order By: Relevance
“…However, even in children with severe hyperbetalipoproteinemia, typical lesions usually do not appear before adolescence. 3,11 The long period before the lesions occur highlights the rarity of the present case.…”
Section: Discussionmentioning
confidence: 65%
“…However, even in children with severe hyperbetalipoproteinemia, typical lesions usually do not appear before adolescence. 3,11 The long period before the lesions occur highlights the rarity of the present case.…”
Section: Discussionmentioning
confidence: 65%
“…6 The levels of total cholesterol, triglycerides, low-density lipoprotein (LDL), and very-lowdensity lipoprotein (VLDL) are increased, while high-density lipoprotein (HDL) levels are decreased. These abnormalities result from an increase in hepatic cholesterol and lipoprotein synthesis, a decrease in peripheral and hepatic catabolism of serum lipoproteins, and an increase in urinary excretion ofHDL.…”
Section: Manifestations Of Nephrotic Syndromementioning
confidence: 99%
“…Some patients respond to administration of a low dose of an angiotensinconverting enzyme inhibitor or calcium channel blocker with a reduction in proteinuria, although treatment with these agents has been demonstrated to be efficacious only in patients with diabetic nephropathy.~o Patients who have significant hyperlipidemia from chronic nephrotic syndrome are candidates for dietary manipulation and therapy with bile acid resin and lovastatin (Mevacor). 6 The latter agent should be used cautiously, since it has been associatcontinued ed with rhabdomyolysis in some nephrotic patients.…”
Section: Primary Nephrotic Syn-mentioning
confidence: 99%
“…Μέρος της υγιεινής διατροφής που πρέπει να ακολουθείται είναι η χρήση πολυακόρεστων λιπαρών οξέων. Τελευταία συζητείται η πιθανή χορήγηση παραγόντων που μειώνουν τα Λίπη στην κυκλοφορία, όπως η χολεστυραμίνη (112)(113)(114)(115)(116)(117)(118)(119)(120)(121)(122)(123)(124)(125)194,195,215 Ως ολιγουρία ορίστηκε η αποβολή ούρων <200 ml/m 2 επιφάνειας σώματος/24ωρο, ενώ ως ανουρία η μηδενική αποβολή ούρων ή η αποβολή ολίγων ml το 8ωρο.…”
Section: δομη και συνθεση του πεπτιδιουunclassified